Cargando…
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination
BACKGROUND: Initiated in 2016, End Hep C SF is a comprehensive initiative to eliminate hepatitis C (HCV) infection in San Francisco. The introduction of direct-acting antivirals to treat and cure HCV provides an opportunity for elimination. To properly measure progress, an estimate of baseline HCV p...
Autores principales: | Facente, Shelley N., Grebe, Eduard, Burk, Katie, Morris, Meghan D., Murphy, Edward L., Mirzazadeh, Ali, Smith, Aaron A., Sanchez, Melissa A., Evans, Jennifer L., Nishimura, Amy, Raymond, Henry F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895024/ https://www.ncbi.nlm.nih.gov/pubmed/29641546 http://dx.doi.org/10.1371/journal.pone.0195575 |
Ejemplares similares
-
Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination
por: Facente, Shelley N., et al.
Publicado: (2018) -
Hepatitis C mortality trends in San Francisco: can we reach elimination targets?
por: Mirzazadeh, Ali, et al.
Publicado: (2022) -
Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019
por: Facente, Shelley N., et al.
Publicado: (2022) -
Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco
por: Mirzazadeh, Ali, et al.
Publicado: (2021) -
Psychosocial Determinants of HIV Stigma among Men Who Have Sex with Men in San Francisco, California
por: Bhatta, Dharma N., et al.
Publicado: (2021)